Labcorp EBITDA 2010-2024 | LH
Labcorp annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Labcorp EBITDA for the quarter ending December 31, 2024 was $0.385B, a 4478.57% increase year-over-year.
- Labcorp EBITDA for the twelve months ending December 31, 2024 was $1.730B, a 32.8% increase year-over-year.
- Labcorp 2024 annual EBITDA was $1.73B, a 32.8% increase from 2023.
- Labcorp 2023 annual EBITDA was $1.303B, a 33.99% decline from 2022.
- Labcorp 2022 annual EBITDA was $1.974B, a 45.56% decline from 2021.
Labcorp Annual EBITDA
(Millions of US $) |
| 2024 |
$1,730 |
| 2023 |
$1,303 |
| 2022 |
$1,974 |
| 2021 |
$3,626 |
| 2020 |
$3,532 |
| 2019 |
$1,907 |
| 2018 |
$1,878 |
| 2017 |
$1,838 |
| 2016 |
$1,771 |
| 2015 |
$1,457 |
| 2014 |
$1,152 |
| 2013 |
$1,223 |
| 2012 |
$1,256 |
| 2011 |
$1,184 |
| 2010 |
$1,188 |
| 2009 |
$1,139 |
Labcorp Quarterly EBITDA
(Millions of US $) |
| 2024-12-31 |
$385 |
| 2024-09-30 |
$418 |
| 2024-06-30 |
$452 |
| 2024-03-31 |
$476 |
| 2023-12-31 |
$8 |
| 2023-09-30 |
$413 |
| 2023-06-30 |
$409 |
| 2023-03-31 |
$472 |
| 2022-12-31 |
$76 |
| 2022-09-30 |
$507 |
| 2022-06-30 |
$540 |
| 2022-03-31 |
$851 |
| 2021-12-31 |
$540 |
| 2021-09-30 |
$953 |
| 2021-06-30 |
$891 |
| 2021-03-31 |
$1,242 |
| 2020-12-31 |
$1,478 |
| 2020-09-30 |
$1,660 |
| 2020-06-30 |
$442 |
| 2020-03-31 |
$-48 |
| 2019-12-31 |
$492 |
| 2019-09-30 |
$484 |
| 2019-06-30 |
$477 |
| 2019-03-31 |
$454 |
| 2018-12-31 |
$445 |
| 2018-09-30 |
$477 |
| 2018-06-30 |
$508 |
| 2018-03-31 |
$448 |
| 2017-12-31 |
$475 |
| 2017-09-30 |
$460 |
| 2017-06-30 |
$457 |
| 2017-03-31 |
$446 |
| 2016-12-31 |
$412 |
| 2016-09-30 |
$446 |
| 2016-06-30 |
$490 |
| 2016-03-31 |
$422 |
| 2015-12-31 |
$352 |
| 2015-09-30 |
$429 |
| 2015-06-30 |
$440 |
| 2015-03-31 |
$236 |
| 2014-12-31 |
$277 |
| 2014-09-30 |
$300 |
| 2014-06-30 |
$310 |
| 2014-03-31 |
$265 |
| 2013-12-31 |
$275 |
| 2013-09-30 |
$303 |
| 2013-06-30 |
$327 |
| 2013-03-31 |
$318 |
| 2012-12-31 |
$275 |
| 2012-09-30 |
$303 |
| 2012-06-30 |
$333 |
| 2012-03-31 |
$345 |
| 2011-12-31 |
$306 |
| 2011-09-30 |
$298 |
| 2011-06-30 |
$285 |
| 2011-03-31 |
$295 |
| 2010-12-31 |
$293 |
| 2010-09-30 |
$287 |
| 2010-06-30 |
$322 |
| 2010-03-31 |
$286 |
| 2009-12-31 |
$267 |
| 2009-09-30 |
$286 |
| 2009-06-30 |
$296 |
| 2009-03-31 |
$291 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$21.029B |
$13.009B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
